These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21623623)

  • 1. Interim guidance for PrEP in MSM. CDC: Do not expand to other risk groups yet.
    AIDS Alert; 2011 Apr; 26(4):44-5. PubMed ID: 21623623
    [No Abstract]   [Full Text] [Related]  

  • 2. PrEP politics.
    Lindsey K
    Posit Aware; 2013; 25(5):15-6. PubMed ID: 25358202
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention. Using PrEP cost-effective in high-risk MSM groups.
    AIDS Policy Law; 2012 Jun; 27(7):1. PubMed ID: 22803211
    [No Abstract]   [Full Text] [Related]  

  • 4. CDC launches prevention efforts focused on PrEP, high-risk groups.
    AIDS Policy Law; 2015 May; 30(6):1, 4. PubMed ID: 26117851
    [No Abstract]   [Full Text] [Related]  

  • 5. PrEP trial in women halted due to doubts that it could show efficacy.
    McEnery R
    IAVI Rep; 2011; 15(2):21. PubMed ID: 21608329
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.
    Cohen J
    Science; 2010 Dec; 330(6009):1298-9. PubMed ID: 21127220
    [No Abstract]   [Full Text] [Related]  

  • 7. Gay community to test HIV prevention pill.
    Bateman C
    S Afr Med J; 2008 Sep; 98(9):660-1. PubMed ID: 19113040
    [No Abstract]   [Full Text] [Related]  

  • 8. Transmission. Company halts Truvada PrEP for women study.
    AIDS Policy Law; 2011 Jun; 26(7):1. PubMed ID: 21735622
    [No Abstract]   [Full Text] [Related]  

  • 9. PrEP in the real world.
    Mastro TD
    Posit Aware; 2013; 25(5):8-9. PubMed ID: 25358199
    [No Abstract]   [Full Text] [Related]  

  • 10. PrEP in practice.
    Wheeler D
    Posit Aware; 2013; 25(5):10-1. PubMed ID: 25358200
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS research. Complexity surrounds HIV prevention advances.
    Cohen J
    Science; 2011 Jul; 333(6041):393. PubMed ID: 21778370
    [No Abstract]   [Full Text] [Related]  

  • 12. CDC promotes pre-exposure prophylaxis for HIV prevention.
    Roehr B
    BMJ; 2014 May; 348():g3384. PubMed ID: 24841703
    [No Abstract]   [Full Text] [Related]  

  • 13. In brief: Truvada for HIV prevention.
    Med Lett Drugs Ther; 2012 Aug; 54(1396):63-4. PubMed ID: 22869292
    [No Abstract]   [Full Text] [Related]  

  • 14. Uptake of PrEP for HIV slow among MSM.
    Kirby T; Thornber-Dunwell M
    Lancet; 2014 Feb; 383(9915):399-400. PubMed ID: 24494225
    [No Abstract]   [Full Text] [Related]  

  • 15. THOUGHTS ON PrEP--FROM THE FIRST PERSON CURED OF HIV.
    Brown TR
    Posit Aware; 2015; 27(1):44-5. PubMed ID: 26302586
    [No Abstract]   [Full Text] [Related]  

  • 16. Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?
    Curran JW; Crosby RA
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S163-6. PubMed ID: 23253761
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-exposure prophylaxis for HIV: can it be implemented in the real world?
    Katz MH
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S161-2. PubMed ID: 23253760
    [No Abstract]   [Full Text] [Related]  

  • 18. From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.
    Warren MJ; Bass ES
    Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S167-70. PubMed ID: 23253762
    [No Abstract]   [Full Text] [Related]  

  • 19. The new revolution: HIV prevention in a pill.
    Grant R
    Posit Aware; 2013; 25(5):2-5. PubMed ID: 25358197
    [No Abstract]   [Full Text] [Related]  

  • 20. PrEPPING for the future.
    Brooks J
    Posit Aware; 2013; 25(5):18-9. PubMed ID: 25358203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.